Onyx Biotec Ltd

Onyx Biotec has shown consistent growth in net sales and profitability over the past three years, with net sales increasing from 39.48 Cr in Mar'23 to 61.95 Cr in Mar'25, and profit after tax rising from 1.84 Cr to 4.95 Cr during the same period. The company's operating profit margin improved from 11.27% to 16.69%, reflecting strong financial performance.

As of 12-Nov, Onyx Biotec Ltd's stock price is at 42.80, up 1.9%, with a significant increase in delivery volume indicating rising investor interest. Despite outperforming the Sensex over the past week, the stock has a year-to-date decline of 28.07%, reflecting ongoing challenges.

As of 28-Oct, Onyx Biotec Ltd's stock price is at 40.50, down 4.71%, and has underperformed its sector. The stock has declined 5.81% over the past week and 9.90% in the last month, contrasting sharply with the Sensex's gains.

As of 23-Oct, Onyx Biotec Ltd's stock price is rising at 44.30, up 3.02%, but has a year-to-date decline of 25.55%, contrasting with the Sensex's gain of 9.50%. While it outperformed its sector in the short term, its longer-term performance remains concerning.

As of 20-Oct, Onyx Biotec Ltd's stock price is Rs 36.30, down 14.39%, with significant underperformance reflected in a one-week return of -16.26% and a one-month return of -19.78%. The stock is trading below key moving averages and is near its 52-week low, indicating a bearish trend amidst a generally resilient market.

As of 29-Sep, Onyx Biotec Ltd's stock price is Rs 42.40, down 5.67%, and underperforming its sector. The stock is near its 52-week low, has seen a significant year-to-date decline, and is experiencing decreased investor interest, contributing to its downward trend.

As of 24-Sep, Onyx Biotec Ltd is priced at 45.80, with a week decline of 6.53% and a year-to-date drop of 23.03%. Despite outperforming its sector slightly today, the stock is trading below key moving averages and has seen a significant decrease in investor participation, indicating a lack of confidence.

As of 23-Sep, Onyx Biotec Ltd is priced at 45.80 with no change, reflecting a bearish trend due to recent declines and reduced investor interest. The stock has underperformed significantly compared to the Sensex, with a year-to-date decline of 23.03%.

As of 22-Sep, Onyx Biotec Ltd is priced at Rs 45.80, up 1.22% today but down 4.78% over the past week and 5.76% over the past month. The stock is underperforming compared to the Sensex, with significant declines in investor participation and trading below key moving averages, indicating a bearish trend.

As of 19-Sep, Onyx Biotec Ltd's stock price is Rs. 45.25, down 1.09%, and has reached a 52-week low of Rs. 44.55. The stock is underperforming its sector and broader market trends, with a year-to-date decline of 23.95% despite increased investor participation.

As of 18-Sep, Onyx Biotec Ltd's stock price is Rs. 45.75, down 6.63% and at a new 52-week low, underperforming its sector and the Sensex. Despite a significant increase in delivery volume, the stock shows a bearish trend with a year-to-date decline of 23.11%.

As of September 10, 2025, Onyx Biotec is considered undervalued with a valuation grade of very attractive, supported by a PE ratio of 17.67 and favorable comparisons to peers like Sun Pharma and Divi's Lab, despite a year-to-date stock performance lagging at -18.91% compared to the Sensex's 5.62%.

As of 08-Aug, Onyx Biotec Ltd's stock price is rising to 53.65, with a 7.19% increase, outperforming the declining Sensex. The stock shows strong investor interest, reflected in a significant rise in trading volume and positive price performance over recent weeks.

As of 06-Aug, Onyx Biotec Ltd's stock price is Rs 46.15, down 2.02%, and has declined 4.85% over the past week. The stock is underperforming the market with year-to-date returns of -22.44% and is trading near its 52-week low, indicating a bearish trend and low investor confidence.

As of 05-Aug, Onyx Biotec Ltd's stock price is at 47.10, down 2.89%, with a significant year-to-date decline of 20.84%. Despite increased investor participation, the stock is underperforming compared to the Sensex, which has gained 4.25% this year.

As of 24th July, Onyx Biotec Ltd has a market capitalization of 90.00 Cr, classifying it as a Micro Cap company. There is no valid data available for recent net sales, net profit, shareholder's funds, or total assets.

Onyx Biotec Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology industry, incorporated in 2005 and converted to a Public Limited company in 2024. It currently has no available sales or profit data, with a market cap of INR 90 Cr and a P/E ratio of 18.00.

As of 08-Jul, Onyx Biotec Ltd's stock price is Rs 46.35, down 4.43%, with significant underperformance reflected in a 1-week return of -9.12% and a year-to-date return of -22.10%. The stock is trading below all key moving averages and is close to its 52-week low, indicating negative investor sentiment.

As of 25-Jun, Onyx Biotec Ltd's stock price is 52.95, down 4.94% today and underperforming its sector. Despite a positive return over the past week and month, it has a year-to-date decline of 11.01%, with significantly decreased delivery volume indicating reduced investor participation.